<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35853576</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Postural orthostatic tachycardia syndrome as a sequela of COVID-19.</ArticleTitle><Pagination><StartPage>1880</StartPage><EndPage>1889</EndPage><MedlinePgn>1880-1889</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2022.07.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(22)02185-3</ELocationID><Abstract><AbstractText>Postural orthostatic tachycardia syndrome (POTS) is a complex multisystem disorder characterized by orthostatic intolerance and tachycardia and may be triggered by viral infection. Recent reports indicate that 2%-14% of coronavirus disease 2019 (COVID-19) survivors develop POTS and 9%-61% experience POTS-like symptoms, such as tachycardia, orthostatic intolerance, fatigue, and cognitive impairment within 6-8 months of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Pathophysiological mechanisms of post-COVID-19 POTS are not well understood. Current hypotheses include autoimmunity related to SARS-CoV-2 infection, autonomic dysfunction, direct toxic injury by SARS-CoV-2 to the autonomic nervous system, and invasion of the central nervous system by SARS-CoV-2. Practitioners should actively assess POTS in patients with post-acute COVID-19 syndrome symptoms. Given that the symptoms of post-COVID-19 POTS are predominantly chronic orthostatic tachycardia, lifestyle modifications in combination with the use of heart rate-lowering medications along with other pharmacotherapies should be considered. For example, ivabradine or &#x3b2;-blockers in combination with compression stockings and increasing salt and fluid intake has shown potential. Treatment teams should be multidisciplinary, including physicians of various specialties, nurses, psychologists, and physiotherapists. Additionally, more resources to adequately care for this patient population are urgently needed given the increased demand for autonomic specialists and clinics since the start of the COVID-19 pandemic. Considering our limited understanding of post-COVID-19 POTS, further research on topics such as its natural history, pathophysiological mechanisms, and ideal treatment is warranted. This review evaluates the current literature available on the associations between COVID-19 and POTS, possible mechanisms, patient assessment, treatments, and future directions to improving our understanding of post-COVID-19 POTS.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ormiston</LastName><ForeName>Cameron K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, San Diego, California; Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15a;wi&#x105;tkiewicz</LastName><ForeName>Iwona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, San Diego, California; Department of Cardiology and Internal Medicine, Nicolaus Copernicus University Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taub</LastName><ForeName>Pam R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, San Diego, California. Electronic address: ptaub@health.ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK118278</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL136407</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054972" MajorTopicYN="Y">Postural Orthostatic Tachycardia Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054971" MajorTopicYN="Y">Orthostatic Intolerance</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013610" MajorTopicYN="N">Tachycardia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autonomic dysfunction</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Dysautonomia</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Orthostatic intolerance</Keyword><Keyword MajorTopicYN="N">POTS</Keyword><Keyword MajorTopicYN="N">Postural orthostatic tachycardia syndrome</Keyword><Keyword MajorTopicYN="N">Post&#x2013;COVID-19 POTS</Keyword><Keyword MajorTopicYN="N">Tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35853576</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pii">S1547-5271(22)02185-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zadourian A., Doherty T.A., Swiatkiewicz I., Taub P.R. Postural orthostatic tachycardia syndrome: prevalence, pathophysiology, and management. Drugs. 2018;78:983&#x2013;994.</Citation><ArticleIdList><ArticleId IdType="pubmed">29943373</ArticleId></ArticleIdList></Reference><Reference><Citation>Karas B., Grubb B.P., Boehm K., Kip K. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiol. 2000;23:344&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">10750135</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubb B.P. Postural tachycardia syndrome. Circulation. 2008;117:2814&#x2013;2817.</Citation><ArticleIdList><ArticleId IdType="pubmed">18506020</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R. Postural tachycardia syndrome (POTS) Circulation. 2013;127:2336&#x2013;2342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756553</ArticleId><ArticleId IdType="pubmed">23753844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryarly M., Phillips L.T., Fu Q., Vernino S., Levine B.D. Postural orthostatic tachycardia syndrome: JACC focus seminar. J Am Coll Cardiol. 2019;73:1207&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pubmed">30871704</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Arnold A.C., Barboi A., et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31:365&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee. Gluckman T.J., Bhave N.M., Allen L.A., et al. 2022 ACC Expert Consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play. J Am Coll Cardiol. 2022;79:1717&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Taub P.R., Zadourian A., Lo H.C., Ormiston C.K., Golshan S., Hsu J.C. Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2021;77:861&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">33602468</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021;18:508&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland E.M., Celedonio J.E., Raj S.R. Postural tachycardia syndrome: beyond orthostatic intolerance. Curr Neurol Neurosci Rep. 2015;15:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664448</ArticleId><ArticleId IdType="pubmed">26198889</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan J.S., Lyne A., Vaughan C.J. COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. BMJ Case Rep. 2021;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204164</ArticleId><ArticleId IdType="pubmed">34127505</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuttinen M.-G., Zurcher K.S., Khurana N., et al. Imaging findings of pelvic venous insufficiency in patients with postural orthostatic tachycardia syndrome. Phlebology. 2021;36:32&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">32757696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston C.K., Padilla E., Van D.T., et al. May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: a case series. Eur Heart J Case Rep. 2022;6:ytac161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9131024</ArticleId><ArticleId IdType="pubmed">35620060</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson J.W., Lambert E.A., Sari C.I., et al. Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS) Front Physiol. 2014;5:230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4070177</ArticleId><ArticleId IdType="pubmed">25009504</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald C., Koshi S., Busner L., Kavi L., Newton J.L. Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: a UK perspective. BMJ Open. 2014;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4067814</ArticleId><ArticleId IdType="pubmed">24934205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourne K.M., Chew D.S., Stiles L.E., et al. Postural orthostatic tachycardia syndrome is associated with significant employment and economic loss. J Intern Med. 2021;290:203&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9156448</ArticleId><ArticleId IdType="pubmed">33586284</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M., St&#xe5;hlberg M., Runold M., et al. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021;3:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyner M.J., Masuki S. POTS versus deconditioning: the same or different? Clin Auton Res. 2008;18:300&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3770293</ArticleId><ArticleId IdType="pubmed">18704621</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Yu X., Liles C., et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959717</ArticleId><ArticleId IdType="pubmed">24572257</ArticleId></ArticleIdList></Reference><Reference><Citation>Watari M., Nakane S., Mukaino A., et al. Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol. 2018;5:486&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899914</ArticleId><ArticleId IdType="pubmed">29687025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Li H., Murphy T.A., et al. Angiotensin II type 1 receptor autoantibodies in postural tachycardia syndrome. J Am Heart Assoc. 2018;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015435</ArticleId><ArticleId IdType="pubmed">29618472</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning W.T., III, Kvale H., Kramer P.M., Karabin B.L., Grubb B.P. Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies. J Am Heart Assoc. 2019;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6818019</ArticleId><ArticleId IdType="pubmed">31495251</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden J., Almskog L., Liliequist A., et al. Thromboembolism, hypercoagulopathy, and antiphospholipid antibodies in critically ill coronavirus disease 2019 patients: a before and after study of enhanced anticoagulation. Crit Care Explor. 2020;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7752689</ArticleId><ArticleId IdType="pubmed">33364605</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Y.L., Leong H.N., Hsu L.Y., et al. Autonomic dysfunction in recovered severe acute respiratory syndrome patients. Can J Neurol Sci. 2005;32:264.</Citation><ArticleIdList><ArticleId IdType="pubmed">16018168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau S.-T., Yu W.-C., Mok N.-S., Tsui P.-T., Tong W.-L., Cheng S.W.C. Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS) Int J Cardiol. 2005;100:167&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132412</ArticleId><ArticleId IdType="pubmed">15820302</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Fern&#xe1;ndez-D&#xed;az E., et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95:e1060&#x2013;e1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocher R.A., Padilla E., Hsu J.C., Taub P.R. Clinical and laboratory improvement in hyperadrenergic postural orthostatic tachycardia syndrome (POTS) after COVID-19 infection. Case Rep Cardiol. 2021;2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8405341</ArticleId><ArticleId IdType="pubmed">34471549</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M., Reistam U., Fedorowski A., et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134:1451&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey P., Ang Y., Sultan J. COVID-19-induced sarcopenia and physical deconditioning may require reassessment of surgical risk for patients with cancer. World J Surg Oncol. 2021;19:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798369</ArticleId><ArticleId IdType="pubmed">33430881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavi L. Postural tachycardia syndrome and long COVID: an update. Br J Gen Pract. 2021;72:8&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714530</ArticleId><ArticleId IdType="pubmed">34972793</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen N.W., Stiles L.E., Miglis M.G. Preparing for the long-haul: autonomic complications of COVID-19. Auton Neurosci. 2021;235</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254396</ArticleId><ArticleId IdType="pubmed">34265539</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis M.G., Prieto T., Shaik R., Muppidi S., Sinn D.-I., Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30:449&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan A., Jennings G., Xue F., Byrne L., Duggan E., Romero-Ortuno R. Orthostatic intolerance in adults reporting long COVID symptoms was not associated with postural orthostatic tachycardia syndrome. Front Physiol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8931464</ArticleId><ArticleId IdType="pubmed">35309052</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31:385&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilmot A., Maldonado Slootjes S., Sellimi A., et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2021;268:751&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391231</ArticleId><ArticleId IdType="pubmed">32734353</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.-M., Wong R.S.-M., Wu E.B., et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82:140&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2596695</ArticleId><ArticleId IdType="pubmed">16461478</ArticleId></ArticleIdList></Reference><Reference><Citation>Andargie T.E., Tsuji N., Seifuddin F., et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8119224</ArticleId><ArticleId IdType="pubmed">33651717</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome? Mol Neurobiol. 2022;59:1850&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42:1866&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.-M., Shang Y.-M., Song W.-B., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.-F., Queneau M., Farid K., Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022;269:44&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., He W., Lan Y., et al. The evidence of porcine hemagglutinating encephalomyelitis virus induced nonsuppurative encephalitis as the cause of death in piglets. PeerJ. 2016;4:e2443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5028786</ArticleId><ArticleId IdType="pubmed">27672502</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatoon F., Prasad K., Kumar V. Neurological manifestations of COVID-19: available evidences and a new paradigm. J Neurovirol. 2020;26:619&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444681</ArticleId><ArticleId IdType="pubmed">32839951</ArticleId></ArticleIdList></Reference><Reference><Citation>Yachou Y., El Idrissi A., Belapasov V., Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41:2657&#x2013;2669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385206</ArticleId><ArticleId IdType="pubmed">32725449</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92:699&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin R., Feng W., Wang T., et al. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019. J Med Virol. 2020;92:1782&#x2013;1784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262032</ArticleId><ArticleId IdType="pubmed">32293714</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghi A., Ramezani M., Roozbeh M., Darazam I.A., Sahraian M.A. A case of possible atypical demyelinating event of the central nervous system following COVID-19. Mult Scler Relat Disord. 2020;44</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311915</ArticleId><ArticleId IdType="pubmed">32615528</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.-C., Bai W.-Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92:552&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Yang X.O. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib. J Microbiol Immunol Infect. 2020;53:368&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156211</ArticleId><ArticleId IdType="pubmed">32205092</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy H.M., Al-Gareeb A.I., Qusti S., Alshammari E.M., Gyebi G.A., Batiha G.E.-S. Covid-19-induced dysautonomia: a menace of sympathetic storm. ASN Neuro. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586167</ArticleId><ArticleId IdType="pubmed">34755562</ArticleId></ArticleIdList></Reference><Reference><Citation>Toljan K. Letter to the Editor regarding the Viewpoint &#x201c;Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanism&#x201d;. ACS Chem Neurosci. 2020;11:1192&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pubmed">32233443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D., Sperhake J.-P., L&#xfc;tgehetmann M., et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173:268&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles V.G., L&#xfc;tgehetmann M., Lindenmeyer M.T., et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383:590&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley B., Naresh K.N., Roufosse C., et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1:e245&#x2013;e253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440861</ArticleId><ArticleId IdType="pubmed">32844161</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima N., Kumagai H., Iigaya K., et al. Baro-excited neurons in the caudal ventrolateral medulla (CVLM) recorded using the whole-cell patch-clamp technique. Hypertens Res. 2012;35:500&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">22158117</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., Canoll P.D., Klein R.S. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78:682&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., et al. Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies. Clin Med. 2021;21:e63&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Vangundy T.B., Galbreath M.M., et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2010;55:2858&#x2013;2868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2914315</ArticleId><ArticleId IdType="pubmed">20579544</ArticleId></ArticleIdList></Reference><Reference><Citation>Porzionato A., Emmi A., Barbon S., et al. Sympathetic activation: a potential link between comorbidities and COVID-19. FEBS J. 2020;287:3681&#x2013;3688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405290</ArticleId><ArticleId IdType="pubmed">32779891</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo J.A., Mart&#xed;nez-L&#xf3;pez J.P., Carrillo-Lamp&#xf3;n S.A., et al. Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci. 2021;11:760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastitskaya S., Thompson N., Holder D. Selective vagus nerve stimulation as a therapeutic approach for the treatment of ARDS: a rationale for neuro-immunomodulation in COVID-19 disease. Front Neurosci. 2021;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076564</ArticleId><ArticleId IdType="pubmed">33927594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhu B., Obiechina N., Rattu N., Mitra S. Postural orthostatic tachycardia syndrome (POTS) BMJ Case Rep. 2013;2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794314</ArticleId><ArticleId IdType="pubmed">24042210</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijs R.D., Brignole M., Falup-Pecurariu C., et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness. Clin Auton Res. 2021;31:369&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8184725</ArticleId><ArticleId IdType="pubmed">33740206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon R.S., Grubb B.P., II, Olshansky B., et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41&#x2013;e63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5267948</ArticleId><ArticleId IdType="pubmed">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis M.G., Larsen N., Muppidi S. Inappropriate sinus tachycardia in long-COVID and other updates on recent autonomic research. Clin Auton Res. 2022;32:91&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">35129713</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany&#xf3; J., Bazan V., Llad&#xf3;s G., et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep. 2022;12:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W., Zhang Y., Wu C., et al. Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients. Echocardiography. 2021;38:1272&#x2013;1281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444873</ArticleId><ArticleId IdType="pubmed">34184314</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Taieb P., et al. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142:342&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer ME, Taub IB, Kaelber DC. Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis [published online ahead of print March 21, 2022]. medRxiv. https://doi:10.1101/2021.07.23.21260998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.23.21260998</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Levine B.D. Exercise and non-pharmacological treatment of POTS. Auton Neurosci. 2018;215:20&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289756</ArticleId><ArticleId IdType="pubmed">30001836</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Levine B.D. Exercise in the postural orthostatic tachycardia syndrome. Auton Neurosci. 2015;188:86&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4336603</ArticleId><ArticleId IdType="pubmed">25487551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Vangundy T.B., Shibata S., Auchus R.J., Williams G.H., Levine B.D. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension. 2011;58:167&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3142863</ArticleId><ArticleId IdType="pubmed">21690484</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata S., Fu Q., Bivens T.B., Hastings J.L., Wang W., Levine B.D. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. J Physiol. 2012;590:3495&#x2013;3505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3547265</ArticleId><ArticleId IdType="pubmed">22641777</ArticleId></ArticleIdList></Reference><Reference><Citation>George S.A., Bivens T.B., Howden E.J., et al. The International POTS Registry: evaluating the efficacy of an exercise training intervention in a community setting. Heart Rhythm. 2016;13:943&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">26690066</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A.J., Raj S.R. Pharmacotherapy for postural tachycardia syndrome. Auton Neurosci. 2018;215:28&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">29753556</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J., Kim D.-Y., Lee W.-J., et al. Efficacy of propranolol, bisoprolol, and pyridostigmine for postural tachycardia syndrome: a randomized clinical trial. Neurotherapeutics. 2018;15:785&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6095784</ArticleId><ArticleId IdType="pubmed">29500811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaffney F.A., Lane L.B., Pettinger W., Blomqvist C.G. Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia. Chest. 1983;83:436&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">6295714</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibao C., Arzubiaga C., Roberts L.J., II, et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005;45:385&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">15710782</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffin S.T., Black B.K., Biaggioni I., et al. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012;9:1484&#x2013;1490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3419341</ArticleId><ArticleId IdType="pubmed">22561596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh M., Dasa O., Pacenta A., Karabin B., Grubb B. Droxidopa in the treatment of postural orthostatic tachycardia syndrome. Am J Ther. 2017;24:e157&#x2013;e161.</Citation><ArticleIdList><ArticleId IdType="pubmed">27563801</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortunato J.E., Shaltout H.A., Larkin M.M., Rowe P.C., Diz D.I., Koch K.L. Fludrocortisone improves nausea in children with orthostatic intolerance (OI) Clin Auton Res. 2011;21:419&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">21796356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon R., Raj S.R., Rose M.S., et al. Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial. J Am Coll Cardiol. 2016;68:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27364043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross A.J., Ocon A.J., Medow M.S., Stewart J.M. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome. Clin Sci. 2014;126:289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896075</ArticleId><ArticleId IdType="pubmed">23978222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kpaeyeh A.G., Mar P.L., Raj V., et al. Hemodynamic profiles and tolerability of modafinil in the treatment of POTS: a randomized placebo-controlled trial. J Clin Psychopharmacol. 2014;34:738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4239166</ArticleId><ArticleId IdType="pubmed">25222185</ArticleId></ArticleIdList></Reference><Reference><Citation>Okutucu S., G&#xf6;renek B. Review of the 2019 European Society of Cardiology Guidelines for the management of patients with supraventricular tachycardia: what is new, and what has changed? Anatol J Cardiol. 2019;22:282&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6955050</ArticleId><ArticleId IdType="pubmed">31789617</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa R.A., Arnold A.C., Nwazue V.C., et al. Acute volume loading and exercise capacity in postural tachycardia syndrome. J Appl Physiol. 2014;117:663&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157162</ArticleId><ArticleId IdType="pubmed">25059240</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon V.M., Opfer-Gehrking T.L., Novak V., Low P.A. Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin Auton Res. 2000;10:29&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">10750641</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Black B.K., Biaggioni I., et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;120:725&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758650</ArticleId><ArticleId IdType="pubmed">19687359</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja I., Bruehl S., Robertson D. Effect of modafinil on acute pain: a randomized double-blind crossover study. J Clin Pharmacol. 2004;44:1425&#x2013;1427.</Citation><ArticleIdList><ArticleId IdType="pubmed">15545315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassani M., Fathi Jouzdani A., Motarjem S., Ranjbar A., Khansari N. How COVID-19 can cause autonomic dysfunctions and postural orthostatic syndrome? A review of mechanisms and evidence. Neurol Clin Neurosci. 2021;9:434&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661735</ArticleId><ArticleId IdType="pubmed">34909198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K., Jamal S., Kichloo A., Grubb B.P. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Card Rhythm Manag. 2020;11:4302&#x2013;4304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2022;32:e2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzilai M., Jacob G. The effect of ivabradine on the heart rate and sympathovagal balance in postural tachycardia syndrome patients. Rambam Maimonides Med J. 2015;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524401</ArticleId><ArticleId IdType="pubmed">26241226</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald C., Frith J., Newton J.L. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace. 2011;13:427&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3043639</ArticleId><ArticleId IdType="pubmed">21062792</ArticleId></ArticleIdList></Reference><Reference><Citation>Delle Donne G., Ros&#xe9;s Noguer F., Till J., Salukhe T., Prasad S.K., Daubeney P.E.F. Ivabradine in postural orthostatic tachycardia syndrome: preliminary experience in children. Am J Cardiovasc Drugs. 2018;18:59&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">29027608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh M., Sirianni N., Ammari Z., et al. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing Clin Electrophysiol. 2017;40:1242&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">28846151</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliphant C.S., Owens R.E., Bolorunduro O.B., Jha S.K. Ivabradine: a review of labeled and off-label uses. Am J Cardiovasc Drugs. 2016;16:337&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">27405864</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-Month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei L.Y., Chew D.S., Sheldon R.S., Raj S.R. Evaluating and managing postural tachycardia syndrome. Cleve Clin J Med. 2019;86:333&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">31066664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>